CD8A and neoplasm: This latter work supports an earlier report from St Paul and coworkers showing that the CoA synthesis pathway is enriched in CD8+ Tc22 cells, and that fueling T these cells with vitamin B5 boosts their IL-22 production and anti-tumor potential [56].